KUALA LUMPUR, July 12 (Bernama) -- BOTANEE Group introduced its four brands WINONA, WINONA Baby, AOXMED and Beforteen for the first time, showing the professional strength of China's leading dermatology enterprises at the 2023 International Skin Health Summit, held concurrently with the WCD World Dermatology Conference in Singapore.
“In 2015, we made our first appearance in Vancouver WCD with the main brand WINONA. After eight years, WINONA has now become the leading brand of functional skin care products in China.
“Invited to participate in WCD three times this year, we brought four core brands. I hope that after four years, it will bring new impacts to WCD in terms of academic, technical, clinical and social impact,” said BOTANEE Group chairman and president, Guo Zhenyu in a statement.
According to the existing epidemiology, the prevalence rate of atopic dermatitis (AD) in children aged one to seven years in China is 12.94 per cent, and in infants aged one to 12 months is 30.48 per cent.
Director of dermatology department of Beijing Children's Hospital affiliated to Capital Medical University, Professor Ma Lin pointed out that WINONA Baby Cream can be used as a routine emollient to protect children's AD in remission, which can significantly reduce the risk of recurrence of children's AD in maintaining the therapeutic effect.
With the continuous iteration of the efficacy skin care market and consumer demand, BOTANEE has also been committed to promoting brand building. Thereinto, AOXMED is the ingenious research and development (R&D) of BOTANEE for more than 10 years.
It insists on exploring cutting-edge technology and evidence-based science for the two major consumption scenarios of medical beauty and daily life, and provides skin rejuvenation solutions connecting medical beauty and home beauty in series.
As a brand-new acne brand launched by BOTANEE, Beforteen and the team of experts have conducted case studies on more than one million cases, and combined with the artificial intelligence (AI) consultation session, they can provide users with personalised "food+medicine+makeup" according to different types of acne.
According to BOTANEE's 2022 annual report, the company invested about 255 million yuan in R&D expenses, up 124.96 per cent year-on-year, and the R&D rate reached 5.08 per cent. (100 Chinese yuan = RM64.68)
This year, its new central factory, which cost nearly 500 million yuan, has also been officially put into operation, further escorting the company’s brand product quality and sustainable development.
-- BERNAMA
No comments:
Post a Comment